跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MOTUFE 27,5 MICROGRAMOS/PULVERIZACION SUSPENSION PARA PULVERIZACION NASAL - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
MOTUFE 27,5 MICROGRAMOS/PULVERIZACION SUSPENSION PARA PULVERIZACION NASAL
Approved
STANDARD
MOTUFE 27,5 MICROGRAMOS/PULVERIZACION SUSPENSION PARA PULVERIZACION NASAL
Substipharm
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jul 16, 2025
Approval ID
4c8815a85a09b0bc
Company
Substipharm
Type
Standard
Approval Details
Approval Id
4c8815a85a09b0bc
Drug Cima Aemps Name
MOTUFE 27,5 MICROGRAMOS/PULVERIZACION SUSPENSION PARA PULVERIZACION NASAL
Register Number
89929
Holder Company Name
Substipharm
Marketing Company Name
Substipharm
Holder Company Detail Path
/organization/substipharm
Marketing Company Detail Path
/organization/substipharm
Authorization Date
2025-07-16
Dosage Form
SUSPENSIÓN PARA PULVERIZACIÓN NASAL
Dose
27,5 microgramos/pulverización
Route Of Administration
VÍA NASAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Substipharm
Company Detail Path
/organization/substipharm
Company Information
Pharmaceutical Company Name
SUBSTIPHARM
Country Name
France
City Name
paris,ile de france,country_fr
Address
24 RUE ERLANGER
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jul 16, 2025
Approval ID
4c8815a85a09b0bc
Type
Standard
Back to CIMA-AEMPS Approvals